Second generation tyrosine kinase inhibitors prevent disease progression in high-risk (high CIP2A) chronic myeloid leukaemia patients
Year: 2015
Type: article
Study design: Observational Study
Source: Leukemia
DOI: 10.1038/leu.2015.71
Authors: C M Lucas, R J Harris, A K Holcroft, L J Scott, N Carmell, E McDonald, F Polydoros, R E Clark
Institution: University of Liverpool
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G4143055344, G6977511061
OpenAlex ID: W1984551975